Large-scale testing (Phase 3)Study completedNCT00619710What this trial is testingComplicated Skin and Skin Structure InfectionsWho this might be right forSkin InfectionAbscessCellulitis Pfizer 1,000
Large-scale testing (Phase 3)Study completedNCT00772447What this trial is testingChina Registration Study in Patients With Skin InfectionsWho this might be right forSkin DiseasesInfectious AstraZeneca 265
Large-scale testing (Phase 3)Study completedNCT00210899What this trial is testingCeftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsWho this might be right forSkin Diseases, InfectiousSkin Diseases, BacterialStaphylococcal Skin Infections Basilea Pharmaceutica 828
Not applicableUnknownNCT05316298What this trial is testingDiabetic Foot Osteomyelitis Treatment Using Gentamicin-loaded Calcium Sulfate-hydroxyapatite BiocompositeWho this might be right forDiabetic Foot UlcerOsteomyelitisDiabetes Mellitus University Medical Center Groningen 182
Testing effectiveness (Phase 2)Study completedNCT00426933What this trial is testingPhase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure InfectionsWho this might be right forSoft Tissue Infections Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Large-scale testing (Phase 3)Study completedNCT00303550What this trial is testingStudy of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)Who this might be right forSkin Diseases, Bacterial Arpida AG
Testing effectiveness (Phase 2)Study completedNCT03716024What this trial is testingStudy the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)Who this might be right forInfectious Skin DiseaseBacterial Skin Disease Paratek Pharmaceuticals Inc 234
Large-scale testing (Phase 3)Study completedNCT01499277What this trial is testingEvaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin InfectionsWho this might be right forComplicated Skin and Soft Tissue Infection Pfizer 802
Large-scale testing (Phase 3)Study completedNCT00091819What this trial is testingComparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusWho this might be right forStaphylococcal Skin Infection Cumberland Pharmaceuticals 862
Post-approval studies (Phase 4)Study completedNCT01626560What this trial is testingThe Effects of Daptomycin and Cytokines Production in Comparison With VancomycinWho this might be right forCellulitis Hospital Universitario Evangelico de Curitiba 20
Not applicableStudy completedNCT06629506What this trial is testingMicroMatrix® Flex in Tunneling WoundsWho this might be right forPressure InjuryVenous UlcerNecrotizing Soft Tissue Infection+2 more Integra LifeSciences Corporation 25
Large-scale testing (Phase 3)Study completedNCT00423657What this trial is testingComparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsWho this might be right forBacterial Infections Forest Laboratories 680
Large-scale testing (Phase 3)Ended earlyNCT00430937What this trial is testingEfficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue InfectionsWho this might be right forSkin Diseases, InfectiousSoft Tissue Infections Novartis Pharmaceuticals 194
Post-approval studies (Phase 4)Study completedNCT00087490What this trial is testingSkin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)Who this might be right forSkin/Soft Tissue InfectionsMethicillin Resistant Staphylococcus Aureus (MRSA) Pfizer 1,077
Post-approval studies (Phase 4)Ended earlyNCT00463801What this trial is testingSafety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure InfectionsWho this might be right forStaphylococcal Skin Infections Novartis 52
Not applicableNot Yet RecruitingNCT06490185What this trial is testingPeri-appendiceal Abscess and Phlegmon in Acute Complicated Appendicitis PatientsWho this might be right forAcute Complicated Appendicitis With Peri-appendiceal Abscess or Phlegmon Shanghai Zhongshan Hospital 150
Large-scale testing (Phase 3)Study completedNCT00228982What this trial is testingCeftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsWho this might be right forSkin Diseases, InfectiousSkin Diseases, BacterialStaphylococcal Skin Infections Basilea Pharmaceutica 784
Large-scale testing (Phase 3)Study completedNCT00299520What this trial is testingPhase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)Who this might be right forComplicated Skin and Skin Structure Infection Arpida AG
Post-approval studies (Phase 4)Study completedNCT01549613What this trial is testingEvaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure InfectionsWho this might be right forCellulitisSkin Infections University of Cincinnati 104
Post-approval studies (Phase 4)Ended earlyNCT01104662What this trial is testingStudy of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal ImpairmentWho this might be right forComplicated Skin and Skin Structure InfectionsS. Aureus BacteremiaRenal Impairment Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 92